MRVI FY 2025 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$186M-28.3% YoY

Gross Profit

$33M18.0% margin

Operating Income

-$7M-3.6% margin

Net Income

-$131M-70.4% margin

EPS (Diluted)

$-0.91

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$71M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$771M

Total Liabilities

$398M

Stockholders' Equity

$212M

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$186M	$259M	-28.3%
Gross Profit	$33M	$108M	-69.2%
Operating Income	-$7M	-$236M	+97.1%
Net Income	-$131M	-$145M	+9.7%